ATE286723T1 - METHOD FOR PRODUCING PERORALLY APPLICABLE SOLID MEDICINAL FORMS WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS - Google Patents

METHOD FOR PRODUCING PERORALLY APPLICABLE SOLID MEDICINAL FORMS WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS

Info

Publication number
ATE286723T1
ATE286723T1 AT98928152T AT98928152T ATE286723T1 AT E286723 T1 ATE286723 T1 AT E286723T1 AT 98928152 T AT98928152 T AT 98928152T AT 98928152 T AT98928152 T AT 98928152T AT E286723 T1 ATE286723 T1 AT E286723T1
Authority
AT
Austria
Prior art keywords
producing
active ingredients
controlled release
solid medicinal
medicinal forms
Prior art date
Application number
AT98928152T
Other languages
German (de)
Inventor
Michael Dittgen
Sabine Fricke
Carsten Timpe
Hagen Gerecke
Annette Eichardt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of ATE286723T1 publication Critical patent/ATE286723T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98928152T 1997-04-29 1998-04-07 METHOD FOR PRODUCING PERORALLY APPLICABLE SOLID MEDICINAL FORMS WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS ATE286723T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19718012A DE19718012C1 (en) 1997-04-29 1997-04-29 Process for the production of orally applicable solid pharmaceutical forms with controlled release of active substances
PCT/DE1998/000979 WO1998048782A1 (en) 1997-04-29 1998-04-07 Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance

Publications (1)

Publication Number Publication Date
ATE286723T1 true ATE286723T1 (en) 2005-01-15

Family

ID=7828056

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928152T ATE286723T1 (en) 1997-04-29 1998-04-07 METHOD FOR PRODUCING PERORALLY APPLICABLE SOLID MEDICINAL FORMS WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS

Country Status (19)

Country Link
US (1) US6117450A (en)
EP (1) EP0979069B1 (en)
JP (1) JP2002511849A (en)
AR (1) AR010414A1 (en)
AT (1) ATE286723T1 (en)
AU (1) AU8009998A (en)
BR (1) BR9809328A (en)
CA (1) CA2290017C (en)
CO (1) CO5070636A1 (en)
CZ (1) CZ300174B6 (en)
DE (2) DE19718012C1 (en)
ES (1) ES2236908T3 (en)
HU (1) HU226670B1 (en)
PL (1) PL191692B1 (en)
PT (1) PT979069E (en)
RU (1) RU2193396C2 (en)
SK (1) SK147999A3 (en)
UA (1) UA49952C2 (en)
WO (1) WO1998048782A1 (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775599B1 (en) 1998-03-09 2001-08-17 Besins Iscovesco Lab PHARMACEUTICAL COMPOSITION BASED ON SYNTHESIS NATURAL PROGESTERONE AND OESTRADIOL AND PROCESS FOR PREPARING THE SAME
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6544553B1 (en) * 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US7025989B2 (en) * 2000-02-24 2006-04-11 Advancis Pharmaceutical Corp. Multiple-delayed released antibiotic product, use and formulation thereof
EP1257255A4 (en) * 2000-02-24 2008-07-30 Advancis Pharmaceutical Corp Therapeutic product, use and formulation thereof
JP2003523372A (en) * 2000-02-24 2003-08-05 アドバンシス ファーマシューティカル コーポレイション Antibiotics and antifungal compositions
WO2001062231A1 (en) * 2000-02-24 2001-08-30 Advancis Pharmaceutical Corporation Antibiotic composition with inhibitor
GB0007419D0 (en) † 2000-03-27 2000-05-17 Smithkline Beecham Gmbh Composition
WO2002055009A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
EP1377276B1 (en) * 2001-04-10 2011-10-05 Sun Pharma Advanced Research Company Limited Timed pulse release composition
AU2007202779B2 (en) * 2001-08-15 2008-08-07 University Of Sheffield Delayed and sustained drug release
GB0119848D0 (en) * 2001-08-15 2001-10-10 Univ Sheffield Delayed and sustained drug release
US20030124196A1 (en) * 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
US20030083286A1 (en) * 2001-08-22 2003-05-01 Ching-Leou Teng Bioadhesive compositions and methods for enhanced intestinal drug absorption
JP2005526059A (en) * 2002-03-07 2005-09-02 アドバンシス ファーマスーティカル コーポレイション Antibiotic composition
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
AU2004258953B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258949B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258944B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2535398C (en) * 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004273830B2 (en) * 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
US9925139B2 (en) 2004-04-22 2018-03-27 Acucort Ab Pharmaceutical compositions for acute glucocorticoid therapy
SE0401031D0 (en) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
US20080014257A1 (en) * 2006-07-14 2008-01-17 Par Pharmaceutical, Inc. Oral dosage forms
GB0817120D0 (en) * 2008-09-19 2008-10-29 Diurnal Ltd Treatment of adrenal insufficiency
CN102448464A (en) * 2009-04-07 2012-05-09 杜奥科特药物公司 Improved glucocorticoid therapy
US20110312927A1 (en) * 2010-06-18 2011-12-22 Satish Kumar Nachaegari Progesterone Containing Oral Dosage Forms and Related Methods
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US9375437B2 (en) * 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
CN105412016B (en) * 2010-10-27 2019-01-22 上海宣泰医药科技有限公司 A kind of enteric solid preparation and preparation method thereof containing lycopene, resveratrol or epiphysin
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (en) 2011-11-23 2021-09-02 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
GB201202433D0 (en) 2012-02-13 2012-03-28 Diurnal Ltd Controlled drug release
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2016014281A (en) 2014-05-22 2017-02-22 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies.
US10570169B2 (en) 2014-05-22 2020-02-25 Ionis Pharmaceuticals, Inc. Conjugated antisense compounds and their use
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US20170035781A1 (en) 2015-06-22 2017-02-09 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (en) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 Steroid hormone pharmaceutical composition
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2403080A1 (en) * 1977-09-15 1979-04-13 Heyden Chem Fab Slow-release nitro:furantoin compsn. useful as urinary antiseptic - comprises three types of granulate with different solubilities
DE2749749A1 (en) * 1977-11-07 1979-05-10 Sumitomo Chemical Co 5-Carboxy-2-acetyl-thiophene prepn. - by oxidising 5-acetyl-2-thienyl-acetic acid with chromic acid or its deriv.
DE2836355A1 (en) * 1978-08-19 1980-02-28 Boehringer Sohn Ingelheim Pharmaceutical preparations in retard form - with active materials in core having semipermeable coating of film former and polymer
IT1101649B (en) * 1978-12-15 1985-10-07 Lehner Ag PROLONGED ACTION PHARMACEUTICAL COMPOSITION CONTAINING BILE ACIDS
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US5229131A (en) * 1990-02-05 1993-07-20 University Of Michigan Pulsatile drug delivery system
IT1243341B (en) * 1990-07-13 1994-06-10 Farcon Ag PHARMACEUTICAL COMPOSITION FOR ORAL USE WITH MODIFIED RELEASE OF NON STEROID ANTI-INFLAMMATORS
ZA919510B (en) * 1990-12-05 1992-10-28 Smithkline Beecham Corp Pharmaceutical compositions
IT1252198B (en) * 1991-12-12 1995-06-05 Bayer Italia Spa PHARMACEUTICAL SYSTEM FOR THERAPEUTICALLY ACTIVE HYDROPYRIDINE CONTROLLED RELEASE ADMINISTRATION AND PREPARATION METHOD
DE4443175A1 (en) * 1994-12-05 1996-06-13 Jenapharm Gmbh New pulsatile drug form
EP0722732A1 (en) * 1995-01-24 1996-07-24 Mitsui Toatsu Chemicals, Inc. Long-acting drug formulation containing pyrimidinedione derivatives
DE19651551C2 (en) * 1996-12-11 2000-02-03 Klinge Co Chem Pharm Fab Opioid antagonist-containing galenic formulation
JP2001507359A (en) * 1997-01-03 2001-06-05 エラン コーポレーション ピーエルシー Sustained release cisapride mini tablet formulation

Also Published As

Publication number Publication date
DE59812485D1 (en) 2005-02-17
RU2193396C2 (en) 2002-11-27
EP0979069B1 (en) 2005-01-12
ES2236908T3 (en) 2005-07-16
EP0979069A1 (en) 2000-02-16
CZ300174B6 (en) 2009-03-04
CZ380499A3 (en) 2000-04-12
HU226670B1 (en) 2009-06-29
CA2290017A1 (en) 1998-11-05
DE19718012C1 (en) 1998-10-08
CO5070636A1 (en) 2001-08-28
PL336572A1 (en) 2000-07-03
US6117450A (en) 2000-09-12
BR9809328A (en) 2000-07-04
UA49952C2 (en) 2002-10-15
AU8009998A (en) 1998-11-24
PT979069E (en) 2005-05-31
SK147999A3 (en) 2000-07-11
CA2290017C (en) 2004-06-29
PL191692B1 (en) 2006-06-30
AR010414A1 (en) 2000-06-07
HUP0003121A3 (en) 2001-03-28
HUP0003121A2 (en) 2001-02-28
JP2002511849A (en) 2002-04-16
WO1998048782A1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
ATE286723T1 (en) METHOD FOR PRODUCING PERORALLY APPLICABLE SOLID MEDICINAL FORMS WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
ATE234124T1 (en) METHOD FOR PRODUCING BONE CEMENTS CONTAINING ACTIVE INGREDIENTS
DE69900449D1 (en) Process for the preparation of glycerol carbonates
DE69635445D1 (en) ALKALIALUMINIUMHYDROXYCARBONATE COMPOSITION AND METHOD OF PREPARING THEREOF
DE69525189D1 (en) Method of making an orthopedic implant
DE19983486T1 (en) Process for the preparation of citalopram
DE69906389D1 (en) PROCESS FOR THE PREPARATION OF CITALOPRAM
DE69829286D1 (en) NEW METHOD FOR PRODUCING SOLID DISPERSIONS CONTAINING PAROXETIN
DE60130878D1 (en) ANTI-REFLECTION LAYER AND METHOD OF MANUFACTURE
DE60108872D1 (en) CONCENTRATE FOR SLUDGE PREPARATION AND METHOD OF MANUFACTURE
DE69725488D1 (en) Process for the preparation of an asphalt composition
DE60043832D1 (en) Composition for the hydrophobization of gypsum, method of manufacture and application
DE69900452D1 (en) Silicone dispersion, composition and method of manufacture
DE60006694D1 (en) METHOD FOR PRODUCING PURE TEREPHTHALIC ACID WITH IMPROVED RECOVERY OF PRECURSORS, SOLVENTS AND METHYL ACETATE
DE60017296D1 (en) Stable emulsion, method of preparation and emulsifier
DE60106933D1 (en) PROCESS FOR THE PREPARATION OF CITALOPRAM
DE59702346D1 (en) IBUPROFEN SHOWER PREPARATION AND METHOD FOR PRODUCING THE SAME
DE69936544D1 (en) EGIOREGULAR COPOLYMER AND METHOD OF PREPARING THEREOF
DE69622804D1 (en) Process for the preparation of optically active 3-hydroxy furan compounds
ATE193296T1 (en) MALTITOL COMPOSITION AND METHOD FOR PREPARATION THEREOF
DE60133280D1 (en) PROCESS FOR THE PREPARATION OF CITALOPRAM
DE69936465D1 (en) CELLOLOSETRIACETATE AND METHOD OF PREPARING THEREOF
HUP9900304A3 (en) Composition for ph dependent controlled release of active ingredients and methods for producing it
DE69935355D1 (en) Process for the preparation of citalopram
DE60001127D1 (en) Layer-forming composition and method of manufacture

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
EELV Lapsed due to withdrawal
REZ Deleted due to withdrawal